Clario
Clario, part of Thermo Fisher Scientific, is a leading provider of endpoint data solutions to the life sciences industry. We offer comprehensive evidence generation solutions that combine eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Since our founding more than 50 years ago, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world. Our endpoint data solutions have supported more than 30,000 clinical trial opportunities in more than 100 countries. Our global team of science, technology, and operational experts have supported over 70% of all FDA drug approvals since 2015. For more information, visit thermofisher.com/clario
Overview
Clario offers a range of technology and services aimed at supporting clinical trials with endpoint data capture, analysis, and evidence generation. They provide tools for cardiac safety, electronic clinical outcome assessments (eCOA), medical imaging, respiratory endpoint,s and precision motion, and they integrate these through software, connected devices, and AI. Their model supports site-based, hybrid, and decentralized trial designs, helping sponsors, biotechs and CROs manage trials across therapeutic areas globally. Their work emphasizes scientific expertise, regulatory compliance across many countries, and a global operational infrastructure.
Tech Stack
Funding History
Venture Round
Undisclosed
May 2016
Novo Holdings
Private Equity Round
Undisclosed
Oct 2019
Astorg, Nordic Capital, Novo Holdings